On February 8, 2024, Pharmadrug Inc. closed the transaction. Each Warrant entitles the holder to purchase one additional common share at an exercise price of CAD 0.10 at any time up to February 8, 2026. The securities issued pursuant to the Offering are subject to a hold period of four months and one day that expires on June 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% | 0.00% | -45.45% |
1st Jan change | Capi. | |
---|---|---|
-45.45% | 2.29M | |
+15.79% | 71.39B | |
+2.09% | 25.1B | |
-0.73% | 8.59B | |
+7.95% | 8.19B | |
-20.48% | 7.91B | |
+15.26% | 4.31B | |
-1.24% | 3.93B | |
-3.02% | 3.86B | |
+21.10% | 3.64B |
- Stock Market
- Equities
- PHRX Stock
- News Pharmadrug Inc.
- Pharmadrug Inc. announced that it has received CAD 0.326 million in funding